Related references
Note: Only part of the references are listed.Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation
Federica Invernizzi et al.
TRANSPLANTATION (2020)
Effectiveness of sorafenib dose modifications on treatment outcome of hepatocellular carcinoma: Analysis in real-life settings
Kwon Yong Tak et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
GUT AND LIVER (2019)
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
Massimo Iavarone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma
Pojen Hsiao et al.
MEDICINE (2019)
New Systemic Treatments in Advanced Hepatocellular Carcinoma
Marco Sanduzzi-Zamparelli et al.
LIVER TRANSPLANTATION (2019)
Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial
Masatoshi Kudo et al.
LIVER CANCER (2019)
Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events
Jordi Rimola et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysis
Mairead Geraldine McNamara et al.
EUROPEAN JOURNAL OF CANCER (2018)
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience
Thomas T. DeLeon et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Gonzalo Sapisochin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Sorafenib: A Review in Hepatocellular Carcinoma
Gillian M. Keating
TARGETED ONCOLOGY (2017)
A Randomized Controlled Trial of Procedural Techniques for Large Volume Paracentesis
Amy R. Shriver et al.
ANNALS OF HEPATOLOGY (2017)
Comparison of hepatocellular carcinoma in Eastern versus Western populations
Su Pin Choo et al.
CANCER (2016)
Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation
Nicola de'Angelis et al.
PROGRESS IN TRANSPLANTATION (2016)
Elevated Alpha-Fetoprotein Differential Diagnosis - Hepatocellular Carcinoma and Other Disorders
Robert J. Wong et al.
CLINICS IN LIVER DISEASE (2015)
Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis
Andrea Mancuso et al.
DIGESTIVE AND LIVER DISEASE (2015)
Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases
Seung Min Jung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2012)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma
Kiminori Uka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression
M Vivarelli et al.
LIVER TRANSPLANTATION (2005)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Share Paper
